What is the role of prognostic indexes in COVID-19 patients with diabetes mellitus? Data of patients from Turkey
| dc.contributor.author | Balin, Safak O. | |
| dc.contributor.author | Kazanci, Ulku | |
| dc.contributor.author | Demirdag, Kutbeddin | |
| dc.contributor.author | Akbulut, Ayhan | |
| dc.date.accessioned | 2026-08-12T17:20:29Z | |
| dc.date.issued | 2022 | |
| dc.department | Fırat Üniversitesi | |
| dc.description.abstract | Aim: We aimed to determine the prognostic performance of the Glasgow Prognostic Score (GPS), systemic immune-inflammation index and early warning score (the 'ANDC' system) in patients with diabetes mellitus who had COVID-19. Patients & methods: Patients were divided into two groups: with and without diabetes mellitus. Results: In the diabetic patient group, the rates of in-hospital mortality, intensive care unit hospitalization and corticosteroid treatment were higher compared with the nondiabetic patient group (p < 0.05). A GPS of 2 was useful for predicting in-hospital mortality in diabetic patients (p < 0.05). The ANDC score was significantly higher in diabetic patients (p < 0.05) and in diabetic patients with mortality and those who needed ICU hospitalization (p < 0.05). Conclusion: The presence of a GPS of 2 at the time of admission and a high ANDC value were associated with poor prognosis in diabetic COVID-19 patients. | |
| dc.identifier.doi | 10.2217/bmm-2022-0250 | |
| dc.identifier.endpage | 979 | |
| dc.identifier.issn | 1752-0363 | |
| dc.identifier.issn | 1752-0371 | |
| dc.identifier.issue | 13 | |
| dc.identifier.orcid | 0000-0003-2560-3265 | |
| dc.identifier.pmid | 36006030 | |
| dc.identifier.scopus | 2-s2.0-85138125526 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 971 | |
| dc.identifier.uri | https://doi.org/10.2217/bmm-2022-0250 | |
| dc.identifier.uri | https://hdl.handle.net/11508/53574 | |
| dc.identifier.volume | 16 | |
| dc.identifier.wos | WOS:000844566800001 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Future Medicine Ltd | |
| dc.relation.ispartof | Biomarkers in Medicine | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WoS_20260511 | |
| dc.subject | COVID-19 | |
| dc.subject | diabetes mellitus | |
| dc.subject | early warning score | |
| dc.subject | Glasgow prognostic score | |
| dc.subject | systemic immune-inflammation index | |
| dc.title | What is the role of prognostic indexes in COVID-19 patients with diabetes mellitus? Data of patients from Turkey | |
| dc.type | Article |







